Can Magnesium Improve Heart and Metabolic Health?
TLDR
A large 2026 systematic review and dose response meta analysis examined 78 randomized controlled trials involving 5,226 adults. Magnesium supplementation produced statistically significant improvements in several cardiometabolic risk factors, including blood pressure, fasting glucose, HbA1c, insulin resistance, LDL cholesterol, HDL cholesterol, triglycerides, body weight, and the inflammatory marker IL 6.
However, the improvements were generally modest. Magnesium did not significantly improve BMI, body fat percentage, waist circumference, total cholesterol, fasting insulin, CRP, or several liver and kidney markers. The researchers emphasized that magnesium should be viewed as a potentially helpful nutritional tool rather than a treatment for cardiovascular or metabolic disease.
Can Magnesium Improve Heart and Metabolic Health?
Magnesium has a reputation for helping with sleep, muscle cramps, relaxation, and exercise recovery.
But its potential benefits may extend much further.
Magnesium is involved in hundreds of biochemical reactions throughout the body, including processes that regulate blood pressure, glucose metabolism, insulin signaling, energy production, inflammation, and cholesterol metabolism.
That has led researchers to ask an important question:
Could taking magnesium actually improve the risk factors associated with heart disease and metabolic disease?
A major new systematic review published in Nutrients in July 2026 provides one of the most comprehensive answers yet.
Researchers combined data from 78 randomized controlled trials involving 5,226 participants and examined nearly every major measure of cardiometabolic health.
The results suggest magnesium may have meaningful effects across several areas, although the size of those improvements needs to be kept in perspective.
Why Magnesium Matters
Magnesium is the fourth most abundant mineral in the human body and serves as a cofactor in more than 300 enzymatic reactions.
These reactions are involved in processes including:
- ATP and energy production
- Glucose regulation
- Protein synthesis
- Lipid metabolism
- Vascular tone
- Neuromuscular function
- Electrolyte balance
Good dietary sources include nuts, seeds, legumes, whole grains, and leafy green vegetables. However, researchers note that inadequate magnesium intake is relatively common, particularly as diets become increasingly dominated by highly processed foods.
Lower magnesium status has also been associated with insulin resistance, inflammation, endothelial dysfunction, oxidative stress, and abnormal lipid metabolism.
All of these processes play a role in cardiometabolic disease.
What Is Cardiometabolic Health?
Cardiometabolic health refers to the collection of factors that influence your risk of conditions such as:
- Cardiovascular disease
- High blood pressure
- Type 2 diabetes
- Metabolic syndrome
- Insulin resistance
- Abnormal cholesterol
- Obesity
Rather than focusing on a single outcome, the researchers wanted to understand whether magnesium could influence several of these interconnected risk factors at the same time.
That is one reason this analysis is particularly interesting.
Previous reviews have usually examined only blood pressure, glucose, cholesterol, or body composition individually.
This review evaluated them together.
The Study
Researchers systematically searched the scientific literature through May 2026 and identified 78 randomized controlled trials that met their criteria.
Altogether, the trials included:
5,226 participants
2,625 receiving magnesium
2,601 in control groups
Participants ranged in average age from approximately 23 to 73 years and represented a wide variety of populations, including healthy adults and people with type 2 diabetes, hypertension, metabolic syndrome, prediabetes, obesity, cardiovascular disease, and other metabolic conditions.
Magnesium doses varied considerably, from 20 to 1,782 mg per day, while intervention durations ranged from 3 to 52 weeks.
Most studies used more moderate protocols.
About 80 percent used at least 300 mg of magnesium per day, and about 67 percent lasted at least 12 weeks.
Researchers then analyzed magnesium's effects on blood pressure, blood sugar regulation, cholesterol, triglycerides, inflammation, body composition, liver health, and kidney health.
Magnesium Lowered Blood Pressure
One of the clearest findings involved blood pressure.
Across 55 comparisons involving more than 3,000 participants, magnesium supplementation reduced:
Systolic blood pressure by an average of 2.50 mmHg
and
Diastolic blood pressure by an average of 1.58 mmHg.
At first glance, a reduction of two or three points might not sound dramatic.
And for an individual person, magnesium should certainly not be expected to replace prescribed blood pressure medication.
But small improvements in cardiovascular risk factors can still be meaningful when they occur consistently across large populations and are combined with improvements in diet, exercise, body weight, sleep, and other lifestyle factors.
The researchers also found that benefits tended to be more pronounced among participants who began with higher blood pressure, suggesting that people with more room for improvement may receive greater benefits.
Magnesium Improved Blood Sugar Control
The glucose findings may be even more interesting.
Magnesium supplementation significantly improved three important markers of glucose regulation.
Fasting Blood Glucose
Fasting glucose declined by an average of:
3.60 mg/dL.
HbA1c
HbA1c, which reflects average blood sugar over roughly the previous two to three months, declined by:
0.15 percentage points.
Insulin Resistance
HOMA IR, a commonly used measure of insulin resistance, also improved significantly.
Interestingly, fasting insulin itself did not significantly change.
Taken together, these findings suggest magnesium may support better glucose handling and insulin sensitivity, rather than simply lowering insulin concentrations.
Why Would Magnesium Affect Blood Sugar?
Magnesium plays a direct role in insulin signaling and glucose metabolism.
When magnesium status is inadequate, cells may respond less effectively to insulin, making it harder for glucose to move from the bloodstream into tissues.
The authors suggest that improved magnesium availability could support several enzymes and signaling pathways involved in glucose metabolism and insulin action.
This could help explain why some of the strongest benefits have historically been observed in people with type 2 diabetes, insulin resistance, prediabetes, or otherwise impaired glucose control.
Importantly, magnesium is not a substitute for diet, exercise, weight management, or diabetes medication when prescribed.
The changes seen in this review were supportive, not curative.
Magnesium Improved Several Cholesterol Markers
Researchers also found favorable changes in blood lipids.
Compared with control groups, magnesium supplementation produced an average:
LDL cholesterol reduction of 3.21 mg/dL
Triglyceride reduction of 9.24 mg/dL
HDL cholesterol increase of 1.45 mg/dL.
Total cholesterol, however, did not significantly change.
Again, these are not enormous shifts.
Nobody should expect magnesium to produce the same cholesterol reduction as a lipid lowering medication when medication is medically indicated.
But the fact that LDL, HDL, and triglycerides all moved in favorable directions suggests magnesium may influence several aspects of lipid metabolism.
One particularly interesting dose response finding was that higher magnesium doses were associated with greater reductions in LDL cholesterol.
That does not mean higher doses are automatically better or appropriate. It simply represents an association observed across the included studies.
Magnesium May Reduce Some Inflammation
Chronic, low grade inflammation is closely connected with cardiometabolic disease.
Researchers examined several commonly measured inflammatory biomarkers.
Magnesium supplementation significantly reduced interleukin 6, or IL 6, by an average of 1.10 pg/mL.
However, the benefits were not universal.
Magnesium did not significantly reduce:
- C reactive protein
- Tumor necrosis factor alpha
This is an important example of why supplement research needs nuance.
It would be inaccurate to simply say:
"Magnesium reduces inflammation."
A more accurate conclusion would be that magnesium may influence certain inflammatory pathways, but current clinical evidence does not show consistent improvements across every inflammatory marker.
The authors themselves noted that previous studies have produced inconsistent results in this area.
What About Weight Loss?
Here is another finding that needs context.
Magnesium supplementation resulted in a statistically significant average body weight reduction of:
0.70 kilograms, or roughly 1.5 pounds.
That sounds promising.
But look at the rest of the body composition data.
There were no significant overall changes in:
- BMI
- Waist circumference
- Hip circumference
- Body fat percentage
That means this study does not provide convincing evidence that magnesium is a meaningful fat loss supplement.
A pound or two of average weight change across multiple trials could result from several factors, and without corresponding reductions in body fat or waist circumference, it would be inappropriate to market magnesium as a weight loss product.
If fat loss is your goal, energy balance, diet quality, exercise, protein intake, sleep, and consistency remain far more important.
Magnesium Did Not Improve Everything
One thing I like about this review is that it gives us a very clear picture of what magnesium did not significantly improve.
No significant overall benefit was found for:
- BMI
- Waist circumference
- Hip circumference
- Body fat percentage
- Total cholesterol
- Fasting insulin
- C reactive protein
- Tumor necrosis factor alpha
- Creatinine
- ALT
- AST
That does not mean magnesium has no biological role in these systems.
It simply means supplementation did not produce a statistically significant improvement in these markers across the randomized trials included in this particular analysis.
That distinction is important.
Does the Dose Matter?
Possibly, but there is no single magic magnesium dose identified by this study.
The majority of trials used at least 300 mg per day, and many of the improvements in glucose, blood pressure, and cholesterol appeared stronger in studies using:
At least 300 mg per day
and
At least 12 weeks of supplementation.
However, the relationship was not perfectly linear.
The researchers found that dose and duration appeared to interact differently depending on the outcome being measured.
For example, magnesium dose had a nonlinear relationship with diastolic blood pressure, while supplementation duration showed nonlinear relationships with fasting glucose, HbA1c, triglycerides, waist circumference, hip circumference, and creatinine.
In plain English:
Taking twice as much magnesium does not necessarily produce twice the benefit.
The optimal amount may depend on the person, their starting magnesium status, the health outcome being targeted, the magnesium formulation, and how long it is taken.
Does the Type of Magnesium Matter?
Potentially.
The studies used numerous forms, including:
- Magnesium citrate
- Magnesium glycinate and other chelated forms
- Magnesium oxide
- Magnesium chloride
- Magnesium lactate
- Magnesium aspartate
- Magnesium sulfate
The researchers categorized these formulations according to estimated bioavailability.
Citrate, lactate, gluconate, aspartate, pidolate, and chelated forms were generally classified as having higher bioavailability, while magnesium oxide and hydroxide were classified as lower bioavailability formulations.
Subgroup analyses suggested that magnesium formulation and bioavailability may influence some cardiometabolic outcomes.
However, the evidence was not strong enough to conclude that one specific form is universally best.
That is worth remembering when you see claims that one form of magnesium is automatically superior for every health goal.
Who Might Benefit Most?
One of the most consistent patterns in the analysis was that magnesium appeared to work better when there was more room for improvement.
Benefits to glucose, lipids, and blood pressure tended to be larger among participants who began with:
- Higher fasting glucose
- Higher triglycerides
- Higher blood pressure
- Lower HDL cholesterol
Longer interventions and doses of at least 300 mg per day also tended to produce stronger metabolic effects in subgroup analyses.
This makes biological sense.
Correcting a nutritional shortfall or metabolic problem generally has greater potential to produce an observable effect than adding more of a nutrient to someone whose status is already adequate.
Unfortunately, one major limitation of this review was that most trials did not specifically recruit people based on magnesium deficiency, meaning researchers could not determine how strongly baseline magnesium status influenced the results.
That is an important question for future studies.
Magnesium Is Helpful, but It Is Not a Cardiovascular Drug
This distinction is crucial.
Many of the results were statistically significant.
But statistically significant does not always mean clinically dramatic.
The authors specifically noted that most improvements were modest and that the clinical significance remains uncertain for several outcomes.
For example:
A 2.5 mmHg reduction in systolic blood pressure is useful.
It is not a cure for hypertension.
A 3.21 mg/dL decrease in LDL cholesterol is favorable.
It is not equivalent to the effect expected from potent cholesterol lowering therapy.
A 0.15 percentage point reduction in HbA1c is encouraging.
It is not a replacement for medical diabetes management.
The most reasonable way to view magnesium is as one potentially supportive component of an overall cardiometabolic health strategy.
Important Limitations
Despite including 78 randomized controlled trials, this review still had several important limitations.
The studies varied considerably in:
- Magnesium dose
- Magnesium formulation
- Treatment duration
- Baseline health status
- Participant age
- Body composition
- Starting magnesium levels
- Other lifestyle factors
Many outcomes also showed substantial statistical heterogeneity, which reduces confidence that everyone will experience the same response.
Another major limitation is that the certainty of evidence varied substantially.
Some findings were backed by moderate or high certainty evidence, while others, including LDL cholesterol and triglycerides, were rated low or very low certainty despite reaching statistical significance.
Researchers also had limited data on doses above 500 mg per day, supplementation lasting more than 25 weeks, and long term safety.
So we should not interpret this research as evidence that everyone should simply take large amounts of magnesium indefinitely.
Simply Good Tip
Before reaching for a supplement, remember that magnesium is naturally abundant in nutrient dense foods.
Good sources include:
- Pumpkin seeds
- Almonds
- Cashews
- Beans
- Lentils
- Whole grains
- Spinach and other leafy greens
- Dark chocolate
- Avocado
A food first approach provides magnesium alongside fiber, healthy fats, potassium, polyphenols, and other nutrients that also support cardiovascular and metabolic health.
For people who do choose a magnesium supplement, this review suggests that many of the metabolic studies used at least 300 mg per day for 12 weeks or longer. That should not be interpreted as a universal dose recommendation, particularly because supplemental magnesium can cause gastrointestinal side effects and may be inappropriate for some people with impaired kidney function or certain medications.
The Bottom Line
Magnesium is not just a sleep or muscle supplement.
This large systematic review and dose response meta analysis of 78 randomized controlled trials and 5,226 adults suggests magnesium supplementation may positively influence several important markers of cardiovascular and metabolic health.
Researchers found significant improvements in:
- Systolic blood pressure
- Diastolic blood pressure
- Fasting blood glucose
- HbA1c
- Insulin resistance
- LDL cholesterol
- HDL cholesterol
- Triglycerides
- IL 6
- Body weight
But the improvements were generally small to modest, and magnesium did not significantly improve many other measures, including body fat percentage, BMI, total cholesterol, fasting insulin, CRP, or liver and kidney markers.
The message is not that magnesium is a miracle supplement.
It is that adequate magnesium may be one piece of a much larger cardiometabolic health puzzle.
Regular exercise, maintaining a healthy body weight, eating plenty of minimally processed foods, consuming adequate fiber, getting enough sleep, avoiding tobacco, and managing blood pressure, cholesterol, and glucose remain the foundations.
Magnesium may simply help support those foundations.
And for a mineral involved in hundreds of essential reactions throughout the human body, that is still a pretty compelling reason to make sure you are getting enough.
References
- Mohammadi S, Palermo A, Ojani P, et al. Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose Response Meta Analysis. Nutrients. 2026;18:2435.
- Fang X, Wang K, Han D, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all cause mortality: A dose response meta analysis of prospective cohort studies. BMC Medicine. 2016;14:210.
- Del Gobbo LC, Imamura F, Wu JHY, et al. Circulating and dietary magnesium and risk of cardiovascular disease: A systematic review and meta analysis of prospective studies. American Journal of Clinical Nutrition. 2013;98:160 to 173.
- Veronese N, Pizzol D, Smith L, Dominguez LJ, Barbagallo M. Effect of magnesium supplementation on inflammatory parameters: A meta analysis of randomized controlled trials. Nutrients. 2022;14:679.
- Dibaba DT, Xun P, Song Y, Rosanoff A, Shechter M, He K. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: A meta analysis of randomized controlled trials. American Journal of Clinical Nutrition. 2017;106:921 to 929.
- Zhao B, Deng H, Li B, et al. Association of magnesium consumption with type 2 diabetes and glucose metabolism: A systematic review and pooled study with trial sequential analysis. Diabetes/Metabolism Research and Reviews. 2020;36:e3243.
- Simental Mendía LE, Sahebkar A, Rodríguez Morán M, Guerrero Romero F. A systematic review and meta analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacological Research. 2016;111:272 to 282.
Frequently Asked Questions
Does magnesium lower blood pressure?
This meta analysis found that magnesium supplementation reduced systolic blood pressure by an average of 2.50 mmHg and diastolic blood pressure by 1.58 mmHg. The effect was modest and should not be considered a substitute for prescribed hypertension treatment.
Can magnesium lower blood sugar?
Magnesium supplementation was associated with reductions in fasting glucose, HbA1c, and HOMA IR, suggesting a potential benefit for glucose regulation and insulin sensitivity. Fasting insulin itself did not significantly change.
Does magnesium lower cholesterol?
Magnesium produced a small reduction in LDL cholesterol, lowered triglycerides, and modestly increased HDL cholesterol. Total cholesterol did not significantly change.
How much magnesium did the studies use?
Doses varied widely, but 79.5 percent of the randomized trials used at least 300 mg per day, and roughly two thirds lasted at least 12 weeks. The study did not establish one optimal dose for cardiometabolic health.
Is more magnesium better?
Not necessarily. Researchers found that dose response relationships varied depending on the outcome, and higher doses did not universally produce greater benefits. Evidence for doses of at least 500 mg per day was also relatively limited.